When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

NCT00055120 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

283

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
AIDS-Related Opportunistic Infections

Interventions

DRUG: Emtricitabine/tenofovir disoproxil fumarate
DRUG: Lopinavir/ritonavir
DRUG: Stavudine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)